Episurf Submits IDE Application for Episealer Knee

By the end of 2Q18, Episurf Medical will file its Investigational Device Exemption with FDA to initiate a U.S. study of the Episealer® knee implant.

In early 2Q, the company affirmed the establishment of its U.S. subsidiary to conduct clinical studies in support of its regulatory path.

Episurf has developed Episealer personalized implants...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us